This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Peroxisome proliferator-activated receptor 3D structures
From Proteopedia
(Difference between revisions)
| (3 intermediate revisions not shown.) | |||
| Line 10: | Line 10: | ||
**[[4bcr]], [[5hyk]] - hPPARα + ligand<br /> | **[[4bcr]], [[5hyk]] - hPPARα + ligand<br /> | ||
**[[1kkq]] – hPPARα + GW6471 Antagonist + SMRT<br /> | **[[1kkq]] – hPPARα + GW6471 Antagonist + SMRT<br /> | ||
| - | **[[2npa]] - hPPARα + propanoic acid derivative + NCOA1<br /> | ||
**[[2p54]] - hPPARα + NCOA1<br /> | **[[2p54]] - hPPARα + NCOA1<br /> | ||
| + | **[[5azt]] - hPPARα (mutant) + NCOA1 peptide<br /> | ||
**[[2rew]] - hPPARα + azetidinone derivative activator<br /> | **[[2rew]] - hPPARα + azetidinone derivative activator<br /> | ||
**[[2znn]], [[2zno]], [[2znp]], [[2znq]], [[3kdu]], [[3vi8]], [[1i7g]], [[4bcr]], [[5hyk]] - hPPARα + agonist<br /> | **[[2znn]], [[2zno]], [[2znp]], [[2znq]], [[3kdu]], [[3vi8]], [[1i7g]], [[4bcr]], [[5hyk]] - hPPARα + agonist<br /> | ||
| - | **[[3fei]], [[3fej]], [[3g8i]], [[3sp6]] - hPPARα + agonist + NCOA1<br /> | + | **[[3fei]], [[3fej]], [[3g8i]], [[3sp6]], [[6l96]] - hPPARα + agonist + NCOA1 peptide<br /> |
| - | **[[3et1]] - hPPARα + NCOA1 + indole derivative | + | **[[3sp6]] - hPPARα + hPPARγ peptide + agonist<br /> |
| + | **[[6kxx]], [[6kxy]] - hPPARα + peptide + agonist<br /> | ||
| + | **[[7c6q]] - hPPARα + peptide + sanguinarine<br /> | ||
| + | **[[3et1]] - hPPARα + NCOA1 + indole derivative<br /> | ||
| + | **[[6kb7]], [[6kba]] - hPPARα + pyrimidine derivative<br /> | ||
| + | **[[7e5f]], [[7e5g]], [[7e5h]], [[7e5i]] - hPPARα + propanoic acid derivative<br /> | ||
| + | **[[2npa]] - hPPARα + propanoic acid derivative + NCOA1 | ||
| + | **[[6jey]], [[6kax]], [[6kay]], [[6kaz]] ,[[6kb0]], [[6kb1]], [[6kb2]], [[6kb3]], [[6kb4]] ,[[6kb5]], [[6kb6]] ,[[6kb8]], [[6kb9]], [[6lx4]], [[6lx5]], [[6lx6]], [[6lx7]], [[6lx8]], [[6lx9]], [[6lxa]], [[6lxb]], [[6lxc]] - hPPARα + ampiphatic carboxylic acid derivative<br /> | ||
| + | **[[7bpy]], [[7bpz]], [[7bq0]], [[7bq1]], [[7bq2]], [[7bq3]], [[7bq4]] - hPPARα + NCOA1 + ampiphatic carboxylic acid derivative<br /> | ||
| + | **[[6l38]] - hPPARα + benzamide derivative<br /> | ||
| + | **[[8hun]], [[8huo]] - hPPARα + anti-NASH drug<br /> | ||
| + | **[[6kyp]], [[6l36]], [[6l37]] - hPPARα + benzamide derivative + propanoic acid derivative <br /> | ||
| + | **[[8huq]], [[8huk]], [[8hum]] - hPPARα + NCOA1 peptide + anti-NASH drug<br /> | ||
| + | |||
| + | **[[5azt]] - hPPARα (mutant) + NCOA1 peptide<br /> | ||
*'''PPARγ''';Ligand-binding domain 202-475 | *'''PPARγ''';Ligand-binding domain 202-475 | ||
| - | **[[3prg]], [[2qmv]], [[1prg]] – hPPARγ<br /> | + | **[[3prg]], [[2qmv]], [[1prg]], [[6l8b]], [[6vzo]], [[8cpj]] – hPPARγ<br /> |
| - | **[[6fzy]], [[6fzg]] - hPPARγ (mutant) <br /> | + | **[[6fzy]], [[6fzg]], [[6t1s]], [[6vzn]], [[7cxe]], [[7e2o]] - hPPARγ (mutant) <br /> |
| - | **[[2zk0]], [[2zk1]], [[2zk2]], [[2zk3]], [[2zk4]], [[2zk5]], [[2zk6]], [[3vjh]], [[3vji]], [[4e4k]], [[4e4q]], [[4jl4]], [[5hzc]], [[4ci5]], [[4ci4]], [[6an1]], [[2f4b]], [[1zeo]], [[2ath]], [[2hwq]], [[2hwr]], [[2i4j]], [[2q59]], [[2q8s]], [[3b3k]], [[3bc5]], [[3cds]], [[3g9e]], [[3gbk]], [[3gz9]], [[3ia6]], [[3kdt]], [[3an3]], [[3an4]], [[3noa]], [[3r5n]], [[3r8a]], [[3vso]], [[3vsp]], [[2xkw]], [[3b0q]], [[3ho0]], [[3hod]], [[1knu]], [[1i7i]], [[1nyx]], [[2pob]], [[5azv]], [[6f2l]], [[6c5t]], [[6c5q]], [[5wr1]], [[5wr0]], [[5wqx]], [[6md2]], [[6md4]], [[6md1]], [[6md0]], [[6mcz]], [[6k0t]], [[6avi]], [[6aug]] – hPPARγ + ligand <br /> | + | **[[2zk0]], [[2zk1]], [[2zk2]], [[2zk3]], [[2zk4]], [[2zk5]], [[2zk6]], [[3vjh]], [[3vji]], [[4e4k]], [[4e4q]], [[4jl4]], [[5hzc]], [[4ci5]], [[4ci4]], [[6an1]], [[2f4b]], [[1zeo]], [[2ath]], [[2hwq]], [[2hwr]], [[2i4j]], [[2q59]], [[2q8s]], [[3b3k]], [[3bc5]], [[3cds]], [[3g9e]], [[3gbk]], [[3gz9]], [[3ia6]], [[3kdt]], [[3an3]], [[3an4]], [[3noa]], [[3r5n]], [[3r8a]], [[3vso]], [[3vsp]], [[2xkw]], [[3b0q]], [[3ho0]], [[3hod]], [[1knu]], [[1i7i]], [[1nyx]], [[2pob]], [[5azv]], [[6f2l]], [[6c5t]], [[6c5q]], [[5wr1]], [[5wr0]], [[5wqx]], [[6md2]], [[6md4]], [[6md1]], [[6md0]], [[6mcz]], [[6k0t]], [[6avi]], [[6aug]], [[6qj5]], [[6t9c]], [[6tdc]], [[6vzl]], [[7lot]], [[7jqg]], [[7wox]] – hPPARγ + ligand <br /> |
**[[4l98]], [[4l96]] - hPPARγ (mutant) + ligand<br /> | **[[4l98]], [[4l96]] - hPPARγ (mutant) + ligand<br /> | ||
**[[3r8i]] - hPPARγ + ureidofibrate derivative<br /> | **[[3r8i]] - hPPARγ + ureidofibrate derivative<br /> | ||
**[[6o67]], [[6o68]], [[6dgr]], [[6dgq]], [[6dgo]], [[6dgl]], [[6d8x]], [[6c1i]] - hPPARγ + agonist<br /> | **[[6o67]], [[6o68]], [[6dgr]], [[6dgq]], [[6dgo]], [[6dgl]], [[6d8x]], [[6c1i]] - hPPARγ + agonist<br /> | ||
| - | **[[2g0h]], [[2g0g]], [[2i4p]], [[2i4z]], [[2q5g]], [[2q5p]], [[2q5s]], [[2q61]], [[2q6r]], [[3cdp]], [[3d6d]], [[4em9]], [[4ema]], [[4prg]], [[2q6s]], [[5f9b]], [[4yt1]], [[3wmh]], [[6d3e]] | + | **[[2g0h]], [[2g0g]], [[2i4p]], [[2i4z]], [[2q5g]], [[2q5p]], [[2q5s]], [[2q61]], [[2q6r]], [[3cdp]], [[3d6d]], [[4em9]], [[4ema]], [[4prg]], [[2q6s]], [[5f9b]], [[4yt1]], [[3wmh]], [[6d3e]], [[6l89]], [[7p4e]], [[8dsz]] - hPPARγ + partial agonist<br /> |
| + | **[[7sqb]], [[8dsy]] hPPARγ + inverse agonist<br /> | ||
**[[2om9]] - hPPARγ + cannabinoid<br /> | **[[2om9]] - hPPARγ + cannabinoid<br /> | ||
**[[3b0r]], [[5lsg]], [[4r6s]], [[4r2u]], [[4r06]], [[6dh9]], [[6dcu]], [[6dbh]] - hPPARγ + antagonist<br /> | **[[3b0r]], [[5lsg]], [[4r6s]], [[4r2u]], [[4r06]], [[6dh9]], [[6dcu]], [[6dbh]] - hPPARγ + antagonist<br /> | ||
**[[3osi]], [[3osw]], [[3pba]] - hPPARγ + bisphenol derivative<br /> | **[[3osi]], [[3osw]], [[3pba]] - hPPARγ + bisphenol derivative<br /> | ||
| - | **[[2p4y]], [[3adt]], [[3adu]], [[3adw]], [[3et3]], [[2hfp]], [[3ty0]] - hPPARγ + modulator<br /> | + | **[[2p4y]], [[3adt]], [[3adu]], [[3adw]], [[3et3]], [[2hfp]], [[3ty0]], [[5two]], [[6fzj]], [[6t6b]], [[6y3u]], [[7a7h]], [[8aty]], [[8atz]], [[8cph]], [[8cpi]] - hPPARγ + modulator<br /> |
**[[2zvt]] - hPPARγ (mutant) + modulator<br /> | **[[2zvt]] - hPPARγ (mutant) + modulator<br /> | ||
| - | **[[2vsr]], [[2vst]], [[2vv0]], [[2vv1]], [[2vv2]], [[2vv3]], [[2vv4]], [[3x1i]], [[3x1h]], [[3wj5]], [[3wj4]], [[3po9]], [[3sz1]] - hPPARγ + fatty acid activator<br /> | + | **[[2vsr]], [[2vst]], [[2vv0]], [[2vv1]], [[2vv2]], [[2vv3]], [[2vv4]], [[3x1i]], [[3x1h]], [[3wj5]], [[3wj4]], [[3po9]], [[3sz1]], [[8bf2]], [[8bff]] - hPPARγ + fatty acid activator<br /> |
| - | **[[3ads]], [[3adx]], [[5u5l]], [[4xum]], [[4xuh]], [[4xta]], [[4xld]], [[6d5a]] - hPPARγ + anti-inflammatory drug<br /> | + | **[[6jey]] - hPPARγ + fatty acid<br /> |
| + | **[[6jf0]], [[7efq]] - hPPARγ + fluorescent probe<br /> | ||
| + | **[[6mcz]], [[6md0]], [[6md1]], [[6md2]], [[6qj5]], [[6t9c]] - hPPARγ + ligand<br /> | ||
| + | **[[6tsg]] - hPPARγ + hormone<br /> | ||
| + | **[[3ads]], [[3adx]], [[5u5l]], [[4xum]], [[4xuh]], [[4xta]], [[4xld]], [[6d5a]], [[6o67]], [[6o68]], [[7ahj]], [[7awc]], [[7awd]], [[7e0a]] - hPPARγ + anti-inflammatory drug<br /> | ||
**[[4oj4]] - hPPARγ (mutant) + anti-inflammatory drug<br /> | **[[4oj4]] - hPPARγ (mutant) + anti-inflammatory drug<br /> | ||
**[[3adv]] - hPPARγ + serotonin<br /> | **[[3adv]] - hPPARγ + serotonin<br /> | ||
**[[3k8s]], [[3et0]], [[2yfe]], [[4a4v]], [[4a4w]], [[4jaz]], [[5tto]], [[4pwl]], [[4pvu]], [[5y2t]], [[5y2o]], [[5ugm]], [[6dha]] - hPPARγ + antidiabetic drug<br /> | **[[3k8s]], [[3et0]], [[2yfe]], [[4a4v]], [[4a4w]], [[4jaz]], [[5tto]], [[4pwl]], [[4pvu]], [[5y2t]], [[5y2o]], [[5ugm]], [[6dha]] - hPPARγ + antidiabetic drug<br /> | ||
| - | **[[4o8f]] - hPPARγ (mutant) + antidiabetic drug<br /> | + | **[[4o8f]], [[6vzm]] - hPPARγ (mutant) + antidiabetic drug<br /> |
| + | **[[6md4]] - hPPARγ + oleic acid + antidiabetic drug<br /> | ||
**[[6enq]] - hPPARγ + antifibrotic drug<br /> | **[[6enq]] - hPPARγ + antifibrotic drug<br /> | ||
| + | **[[6zly]] - hPPARγ + valine derivative <br /> | ||
| - | * | + | **[[7qb1]], [[8adf]], [[8c0c]], [[8dkv]] - hPPARγ + inhibitor<br /> |
| + | **[[8hup]] - hPPARg + NCOA1 peptide + anti-NASH drug<br /> | ||
| - | **[[ | + | *PPARγ complex with NCAO1 |
| - | + | ||
| - | + | **[[2gtk]], [[3qt0]], [[5gtp]], [[5gto]], [[5gtn]], [[5ycp]], [[5ycn]], [[5z6s]], [[5z5s]], [[6dgp]], [[6ilq]], [[6ijs]], [[6ijr]], [[6icj]], [[6jq7]], [[6ktm]], [[7cxf]] - hPPARγ + NCOA1 peptide<br /> | |
| - | + | **[[6t1v]], [[7cxg]], [[7cxh]], [[7cxi]], [[7cxj]], [[7cxk]], [[7cxl]] - hPPARγ (mutant) + NCOA1 peptide<br /> | |
| - | + | **[[6ktn]] - hPPARγ (mutant) + NCOA1 peptide + leukemia drug<br /> | |
| - | **[[ | + | **[[3fur]], [[3kmg]], [[3v9t]], [[3v9v]], [[3v9y]], [[4f9m]], [[3b1m]], [[3lmp]], [[6fzp]], [[8dk4]] - hPPARγ + NCOA1+ modulator<br /> |
| - | **[[ | + | **[[6fzf]] - hPPARγ (mutant) + NCOA1+ modulator<br /> |
| - | + | **[[4fgy]], [[2prg]] - hPPARγ + antidiabetic drug + NCOA1 peptide<br /> | |
| - | **[[ | + | **[[7wgo]], [[7wgq]] - hPPARγ + hyperlipidaemia drug + NCOA1 peptide<br /> |
| + | **[[7wgp]] - hPPARγ + pancreatitis drug + NCOA1 peptide<br /> | ||
**[[6ad9]] - hPPARγ + anticancer agent + NCOA1 peptide<br /> | **[[6ad9]] - hPPARγ + anticancer agent + NCOA1 peptide<br /> | ||
| + | **[[6izm]], [[6izn]], [[8dkn]] - hPPARγ + pyridine derivative + NCOA1 peptide<br /> | ||
**[[3s9s]], [[3t03]], [[2fvj]]- hPPARγ + NCOA1 peptide + partial agonist<br /> | **[[3s9s]], [[3t03]], [[2fvj]]- hPPARγ + NCOA1 peptide + partial agonist<br /> | ||
**[[4y29]], [[2fvj]], [[5azt]] - hPPARγ + NCOA1 peptide + ligand<br /> | **[[4y29]], [[2fvj]], [[5azt]] - hPPARγ + NCOA1 peptide + ligand<br /> | ||
| - | **[[3h0a]] - hPPARγ + | + | **[[3h0a]] - hPPARγ + NCOA1 + retinoic acid receptor + retinoic acid + partial agonist<br /> |
| - | **[[1k74]], [[1rdt]], [[1fm9]] - hPPARγ + NCOA1 + retinoic acid receptor | + | **[[1k74]], [[1rdt]], [[1fm9]] - hPPARγ + NCOA1 + retinoic acid receptor + retinoic acid + agonist<br /> |
**[[5ji0]] - hPPARγ + retinoic acid receptor + NCOA1 peptide + antidiabetic drug <br /> | **[[5ji0]] - hPPARγ + retinoic acid receptor + NCOA1 peptide + antidiabetic drug <br /> | ||
| - | **[[3dzu]], [[3e00]], [[3dzy]] - hPPARγ + DNA + retinoic acid receptor α + NCOA2 peptide + retinoic acid<br /> | ||
| - | **[[1fm6]] - hPPARγ + antidiabetic drug + retinoic acid receptor α + NCOA2 peptide + retinoic acid<br /> | ||
**[[3vn2]], [[4hee]], [[4prg]] - hPPARγ + NCOA1 peptide + activator<br /> | **[[3vn2]], [[4hee]], [[4prg]] - hPPARγ + NCOA1 peptide + activator<br /> | ||
| - | **[[ | + | |
| - | **[[ | + | * PPARγ complex with NCAO2 |
| + | |||
| + | **[[1wm0]] – hPPARγ + NCAO2 peptide + agonist<br /> | ||
| + | **[[5dwl]], [[5dvc]], [[5dv8]], [[5dv6]], [[5dv3]], [[5dsh]] - hPPARγ + NCAO2 peptide + inhibitor<br /> | ||
| + | **[[7sqa]], [[8aqm]], [[8aqn]], [[8b8w]], [[8b8x]], [[8b8y]], [[8b90]], [[8b92]], [[8b93]], [[8b94]], [[8b95]]- hPPARγ + NCOA2 peptide + inverse agonist<br /> | ||
| + | **[[8b8z]], [[8b91]] - hPPARγ (mutant) + NCOA2 peptide + inverse agonist<br /> | ||
| + | **[[3dzu]], [[3e00]], [[3dzy]] - hPPARγ + DNA + retinoic acid receptor + NCOA2 peptide + retinoic acid<br /> | ||
| + | **[[1fm6]] - hPPARγ + antidiabetic drug + retinoic acid receptor + NCOA2 peptide + retinoic acid<br /> | ||
| + | |||
| + | * PPARγ complex with other proteins | ||
| + | |||
| + | **[[1zgy]] – hPPARγ + antidiabetic drug + nuclear receptor peptide<br /> | ||
| + | **[[3cs8]], [[3u9q]], [[8bf1]] - hPPARγ + PGC-1A peptide<br /> | ||
| + | **[[3cwd]] - hPPARγ + SRC1-2<br /> | ||
| + | **[[6oni]], [[6pdz]] - hPPARγ +inverse agonist + NCOR peptide<br /> | ||
| + | **[[6ms7]] - hPPARγ + PGC1 LXXLL + modulator<br /> | ||
**[[6d94]] - hPPARγ + mediator of RNA polymerase II peptide<br /> | **[[6d94]] - hPPARγ + mediator of RNA polymerase II peptide<br /> | ||
| + | **[[6onj]] - hPPARγ + mediator of RNA polymerase II peptide + antidiabetic drug<br /> | ||
| + | **[[7rle]] - hPPARγ + CREB-binding protein peptide + agonist<br /> | ||
*'''PPARδ''';Ligand-binding domain 171-441 | *'''PPARδ''';Ligand-binding domain 171-441 | ||
| Line 71: | Line 110: | ||
**[[3dy6]] – hPPARδ + anthranilic acid <br /> | **[[3dy6]] – hPPARδ + anthranilic acid <br /> | ||
**[[3et2]], [[1gwx]] – hPPARδ + fatty acid<br /> | **[[3et2]], [[1gwx]] – hPPARδ + fatty acid<br /> | ||
| - | **[[2j14]], [[2xyj]], [[2xyw]], [[2xyx]], [[3oz0]], [[3sp9]], [[5u3q]], [[5u3r]], [[5u3s]], [[5u3t]], [[5u3u]], [[5u3v]], [[5u3w]], [[5u3x]], [[5u3y]], [[5u3z]], [[5u40]], [[5u41]], [[5u42]], [[5u43]], [[5u44]], [[5u45]], [[1gwx]], [[3tkm]], [[1y0s]], [[5u46]], [[5y7x]] - hPPARδ + agonist<br /> | + | **[[2j14]], [[2xyj]], [[2xyw]], [[2xyx]], [[3oz0]], [[3sp9]], [[5u3q]], [[5u3r]], [[5u3s]], [[5u3t]], [[5u3u]], [[5u3v]], [[5u3w]], [[5u3x]], [[5u3y]], [[5u3z]], [[5u40]], [[5u41]], [[5u42]], [[5u43]], [[5u44]], [[5u45]], [[1gwx]], [[3tkm]], [[1y0s]], [[5u46]], [[5y7x]], [[7vwf]], [[7vwg]], [[7vwh]], [[7w0g]], [[7wgn]], [[8hul]] - hPPARδ + agonist<br /> |
**[[3peq]] - hPPARδ + partial agonist<br /> | **[[3peq]] - hPPARδ + partial agonist<br /> | ||
**[[3d5f]] - hPPARδ + phenoxy derivative<br /> | **[[3d5f]] - hPPARδ + phenoxy derivative<br /> | ||
| - | **[[5xmx]], [[6a6p]], [[5zxi]] - hPPARδ + inhibitor<br /> | + | **[[5xmx]], [[6a6p]], [[5zxi]], [[7f80]] - hPPARδ + inhibitor<br /> |
| + | **[[7wgl]] - hPPARd + hyperlipidaemia drug <br /> | ||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Current revision
3D Structures of PPAR
Updated on 23-August-2023
